Asthma: the new advances.

Area of Science:

• Pulmonology
• Pediatric Asthma
• Inflammatory Airway Diseases

Background:

• Asthma mortality and morbidity rates are increasing globally.
• Traditionally viewed as episodic, asthma is now understood as a chronic inflammatory airway disease.
• Early identification and intervention are crucial for managing persistent asthma.

Purpose of the Study:

• To review current knowledge on asthma pathogenesis and its implications for management.
• To highlight the shift in perspective from episodic to chronic asthma.
• To discuss the role of early anti-inflammatory therapy in altering disease course.

Main Methods:

• Literature review of recent findings on asthma pathogenesis.
• Analysis of the impact of new information on clinical practice guidelines.
• Discussion of the role of inhaled corticosteroids in asthma management.

Main Results:

• Asthma is fundamentally a chronic inflammatory condition.
• Inhaled steroids are the primary anti-inflammatory treatment for chronic persistent asthma.
• A "window of opportunity" for early intervention exists to modify disease progression.

Conclusions:

• Early intervention in asthma, particularly with inhaled steroids, is essential.
• Primary care physicians, especially pediatricians, play a vital role in early asthma diagnosis and management.
• Further research is needed to optimize early therapeutic strategies and explore potential cures for asthma.